MedTrace Logo

Determination of Biological Activity of Human-enriched Serum Following Chondractiv™ Plus Ingredient Ingestion

NCT06800820 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2025-05-16

No results posted yet for this study

Summary

The main objective of this study is, after collecting serum enriched with metabolites of interest resulting from the ingestion of the Chondractiv™ Plus food supplement (an hydrolyzed chicken collagen), to determine the influence of these sera enriched with circulating metabolites on the behavior of human joint cartilage cells placed in culture.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

Chondractiv™ Plus (Hydrolyzed chicken cartilage)

One oral dose

Sponsors & Collaborators

  • Clinic'n'Cell

    collaborator OTHER

  • Symrise Group

    lead INDUSTRY

Principal Investigators

  • Gisèle PICKERING, PhD · CIC Clermont-Ferrand

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-01-23
Primary Completion
2025-04-03
Completion
2025-04-03

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06800820 on ClinicalTrials.gov